I 
117TH CONGRESS 
2D SESSION 
H. R. 7770 
To amend the Family and Medical Leave Act of 1993 to permit additional 
leave for bone marrow or blood stem cell donation, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 13, 2022 
Mr. PHILLIPS introduced the following bill; which was referred to the Com-
mittee on Education and Labor, and in addition to the Committees on 
Oversight and Reform, and House Administration, for a period to be sub-
sequently determined by the Speaker, in each case for consideration of 
such provisions as fall within the jurisdiction of the committee concerned 
A BILL 
To amend the Family and Medical Leave Act of 1993 to 
permit additional leave for bone marrow or blood stem 
cell donation, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Life Saving Leave 
Act’’. 
VerDate Sep 11 2014 
05:50 May 19, 2022
Jkt 000000
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H7770.IH
H7770
pbinns on DSKJLVW7X2PROD with $$_JOB
SEC. 2. ENTITLEMENT TO ADDITIONAL LEAVE FOR BONE 
MARROW OR BLOOD STEM CELL DONATION. 
(a) IN GENERAL.—Section 102(a) of the Family and 
Medical Leave Act of 1993 (29 U.S.C. 2612(a)) is amend-
ed— 
(1) by redesignating paragraph (5) as para-
graph (6); and 
(2) by inserting after paragraph (4) the fol-
lowing: 
‘‘(5) ENTITLEMENT TO ADDITIONAL LEAVE FOR 
BONE MARROW OR BLOOD STEM CELL DONATION.— 
‘‘(A) IN
GENERAL.—Subject to subpara-
graph (B) and section 103(g), an eligible em-
ployee shall be entitled to leave under this para-
graph— 
‘‘(i) for predonation activities relating 
to the making of a donation of bone mar-
row or blood stem cells for transplant; 
‘‘(ii) for the making of such donation; 
and 
‘‘(iii) for postdonation activities relat-
ing to the making of such donation. 
‘‘(B) LIMITATIONS.— 
‘‘(i) IN
GENERAL.—An eligible em-
ployee shall be entitled to a total of 40 
VerDate Sep 11 2014 
05:50 May 19, 2022
Jkt 000000
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H7770.IH
H7770
pbinns on DSKJLVW7X2PROD with $$_JOB
hours of leave under this paragraph during 
any 12-month period. 
‘‘(ii) COORDINATION
RULE.—Leave 
under this paragraph shall be in addition 
to any leave provided under any other 
paragraph of this subsection.’’. 
(b) DEFINITION OF ELIGIBLE EMPLOYEE.—Section 
101(2) of the Family and Medical Leave Act of 1993 (29 
U.S.C. 2611(2)) is amended by adding at the end the fol-
lowing: 
‘‘(F) EMPLOYEES REQUESTING BONE MAR-
ROW OR BLOOD STEM CELL LEAVE.—The re-
quirements of subparagraphs (A) and (B)(ii) 
shall not apply with respect to leave under sec-
tion 102(a)(5).’’. 
(c) SCHEDULE.—Section 102(b)(1) of such Act (29 
U.S.C. 2612(b)(1)) is amended by inserting after the third 
sentence the following: ‘‘Subject to subsection (e)(4) and 
section 103(g), leave under subsection (a)(5) may be taken 
intermittently or on a reduced leave schedule.’’. 
(d) 
SUBSTITUTION
OF
PAID
LEAVE.—Section 
102(d)(2) of such Act (29 U.S.C. 2612(d)(2)) is amended 
by adding at the end the following: 
‘‘(C) BONE
MARROW
OR
BLOOD
STEM 
CELL DONATION LEAVE.—An eligible employee 
VerDate Sep 11 2014 
05:50 May 19, 2022
Jkt 000000
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H7770.IH
H7770
pbinns on DSKJLVW7X2PROD with $$_JOB
may elect, but an employer may not require the 
employee, to substitute any of the accrued paid 
vacation leave, personal leave, or medical or 
sick leave of the employee for leave provided 
under subsection (a)(5) for any part of the 40 
hours of such leave under such subsection, ex-
cept that nothing in this title shall require an 
employer to provide paid sick leave or paid 
medical leave in any situation in which such 
employer would not normally provide any such 
paid leave.’’. 
(e) NOTICE.—Section 102(e) of such Act (29 U.S.C. 
2612(e)) is amended by adding at the end the following: 
‘‘(4) NOTICE RELATING TO BONE MARROW OR 
BLOOD STEM CELL DONATION LEAVE.—In any case 
in which the necessity for leave under subsection 
(a)(5) is foreseeable based on planned predonation, 
donation, or postdonation activities, the employee— 
‘‘(A) shall make a reasonable effort to 
schedule the treatment so as not to disrupt un-
duly the operations of the employer, subject to 
the approval of the relevant health care pro-
vider; and 
‘‘(B) shall provide the employer with not 
less than 30 days’ notice, before the date the 
VerDate Sep 11 2014 
05:50 May 19, 2022
Jkt 000000
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H7770.IH
H7770
pbinns on DSKJLVW7X2PROD with $$_JOB